slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,731-5,760
Pages 296
Rows per page 30
Slide type
5,731-5,760 of 8,880
10
The slide uses a biological pathway diagram to illustrate the mechanism of action and a callout box for the therapeutic thesis.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
51
Includes a DepMap CRISPR sensitivity chart and a biological process diagram showing the MDM2-p53 feedback loop.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
52
The slide uses a biological pathway diagram to illustrate the mechanism of action and Western blot data to validate the claim.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
55
The slide uses a series of bar charts to demonstrate the mechanism of action of the drug candidate KT-253 compared to vehicle and DS-3032.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
58
The slide uses a split-layout to contrast mechanism benefits (left) with strategic market opportunity (right).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
08
The slide uses a hub-and-spoke diagram to illustrate the integrated nature of their service offerings.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations Beat · Solution1 hit
09
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Problem1 hit
05
Includes product imagery and regulatory certification (CE-IVD).Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide outlines the technical workflow from sample collection to diagnostic output.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
The slide details the technical workflow from sample collection (FIT tube and DNA stabilization tube) through analysis to the final patient report.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
Uses a 'Before-After-Bridge' style logic to frame the solution.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Uses a process/timeline diagram to show life cycle management.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
Includes a scientific diagram of the LNC structure and a list of key performance attributes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
19
The slide uses a process diagram to show the self-assembly of lipoplexes into PS-NPs.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
20
Technical slide detailing biological mechanism of drug delivery platform.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
08
Uses a brain diagram to visually link specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Uses scientific visualization to illustrate the drug's effect on brain states.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a process diagram to illustrate the biological mechanism of action.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
21
The slide uses a biological process diagram to illustrate the drug's mechanism of action at the synaptic and neural level.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
23
The chart compares Social Interaction vs Locomotor Activity across R, R/S, and S variants.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
20
The slide uses a mix of qualitative service descriptions and quantitative financial performance data.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
20
The slide uses a three-column layout, each featuring a mobile app screenshot representing a specific use case.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations 1 hit
06
Uses a Venn diagram to illustrate the intersection of Kinase Resistance and Kinase Selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
Uses a visual comparison framework to illustrate the mechanism of action and clinical benefit of selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Nuvalent | Investor Presentation Deck | 39 slidesNuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses dot plots for IC50 data and a bar chart for tumor regression efficacy.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
14
The slide uses a bar chart to compare brain penetrance and a grouped bar chart to show selectivity indices across multiple drugs.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
27
The slide uses a list of icons to represent key features of the drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide uses three distinct chart types to demonstrate efficacy, pharmacokinetics, and selectivity.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit